These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4658848)

  • 61. Partial sequence of the tyrosine region of neocarzinostatin.
    Glaser CB; Maeda H; Meienhofer J; Niall HD
    Experientia; 1972 Jul; 28(7):772-3. PubMed ID: 4658848
    [No Abstract]   [Full Text] [Related]  

  • 62. Chemical and biological characterization of succinyl neocarzinostatin.
    Maeda H
    J Antibiot (Tokyo); 1974 May; 27(5):303-11. PubMed ID: 4850987
    [No Abstract]   [Full Text] [Related]  

  • 63. Complete amino acid sequence of phenomycin, an antitumor polypeptide antibiotic.
    Muramatsu R; Abe S; Hayashi H; Yamaguchi K; Jinda K; Sakano K; Inouye Y; Nakamura S
    J Antibiot (Tokyo); 1991 Nov; 44(11):1222-7. PubMed ID: 1761418
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The spectrophotometric determination of tyrosine and tryptophan in proteins.
    Goodwin TW; Morton RA
    Biochem J; 1946; 40(5-6):628-32. PubMed ID: 16748065
    [No Abstract]   [Full Text] [Related]  

  • 65. Peptide separation by two-dimensional chromatography and electrophoresis.
    KATZ AM; DREYER WJ; ANFINSEN CB
    J Biol Chem; 1959 Nov; 234():2897-900. PubMed ID: 14404782
    [No Abstract]   [Full Text] [Related]  

  • 66. NEOCARZINOSTATIN, AN ANTITUMOR ANTIBIOTIC OF HIGH MOLECULAR WEIGHT. ISOLATION, PHYSIOCHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES.
    ISHIDA N; MIYAZAKI K; KUMAGAI K; RIKIMARU M
    J Antibiot (Tokyo); 1965 Mar; 18():68-76. PubMed ID: 14326086
    [No Abstract]   [Full Text] [Related]  

  • 67. Amino and carboxy-terminal sequences of neocarzinostatin, an anti-tumor polypeptide antibiotic.
    Maeda H; Meienhofer J
    FEBS Lett; 1970 Aug; 9(5):301-303. PubMed ID: 11947698
    [No Abstract]   [Full Text] [Related]  

  • 68. A protein sequenator.
    Edman P; Begg G
    Eur J Biochem; 1967 Mar; 1(1):80-91. PubMed ID: 6059350
    [No Abstract]   [Full Text] [Related]  

  • 69. Characterization of neocarzinostatin.
    Maeda H; Kumagai K; Ishida N
    J Antibiot (Tokyo); 1966 Nov; 19(6):253-9. PubMed ID: 6013238
    [No Abstract]   [Full Text] [Related]  

  • 70. Mode of action of neocarzinostatin: inhibition of DNA synthesis and degradation of DNA in Sarcina lutea.
    Ono Y; Watanabe Y; Ishida N
    Biochim Biophys Acta; 1966 Apr; 119(1):46-58. PubMed ID: 5960410
    [No Abstract]   [Full Text] [Related]  

  • 71. Human fibrinopeptides. Isolation, characterization and structure.
    Blombäck B; Blombäck M; Edman P; Hessel B
    Biochim Biophys Acta; 1966 Feb; 115(2):371-96. PubMed ID: 5943441
    [No Abstract]   [Full Text] [Related]  

  • 72. C-terminal amino acid of neocarzinostatin.
    Maeda H; Koyanagi T; Ishida N
    Biochim Biophys Acta; 1968 Jun; 160(2):249-51. PubMed ID: 5658126
    [No Abstract]   [Full Text] [Related]  

  • 73. Mode of action of neocarzinostatin: requirement of protein synthesis for neocarzinostatin-mediated DNA degradation in Sarcina lutea.
    Ono Y; Ito Y; Maeda H; Ishida N
    Biochim Biophys Acta; 1968 Feb; 155(2):616-8. PubMed ID: 5637077
    [No Abstract]   [Full Text] [Related]  

  • 74. Clinical trials of a new antitumor polypeptide: neocarzinostatin (NCS).
    Takahashi M; Toriyama K; Maeda H; Kikuchi M; Kumagai K
    Tohoku J Exp Med; 1969 Jul; 98(3):273-80. PubMed ID: 5347922
    [No Abstract]   [Full Text] [Related]  

  • 75. Revised primary structure for human growth hormone.
    Niall HD
    Nat New Biol; 1971 Mar; 230(11):90-1. PubMed ID: 5279046
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.